Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein (MAP) kinases are proline-directed serine/threonine kinases that are activated by dual phosphorylation on threonine and tyrosine residues in response to a wide array of extracellular stimuli. Three distinct groups of MAP kinases have been identified in mammalian cells [extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38]. These MAP kinases are mediators of signal transduction from the cell surface to the nucleus. One nuclear target of these MAP kinase signaling pathways is the transcription factor AP-1. MAP kinases regulate AP-1 transcriptional activity by multiple mechanisms. Here we review recent progress towards understanding AP-1 regulation by the ERK, JNK, and p38 MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun forms homodimers or can heterodimerize with other Jun family members or with other bZIP proteins including members of the Fos and ATF/cAMP response element-binding protein (CREB) families (18,19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes [69, 70].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [70]
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Self-citationMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationIntegrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citation
Cited by
Items 101–200 of 1,001
Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors
Yang, S.-H., Galanis, A., & Sharrocks, A. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4028 · Cited by 244
Hijacking of the AP-1 Signaling Pathway during Development of ATL
Gazon, H., Barbeau, B., Mesnard, J.-M., & Peloponese, J.-M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02686 · Cited by 250
“The contribution of p38 to AP-1 induction can be mediated by the direct phosphorylation and activation of ATF2 and TCFs (Figure 2; Mendelson et al., 1996; Whitmarsh and Davis, 1996).”
BackgroundKang, S., Chung, J. H., Lee, J. H., Fisher, G. J., Wan, Y. S., Duell, E. A., & Voorhees, J. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12122.x · Cited by 239
“Induction of cJun protein by UV is markedly reduced by genistein and NAC Activation of the ERK and JNK/p38 pathways results in induction of cFos and cJun in cultured cells (Karin and Hunter, 1995;Whitmarsh and Davis, 1996).”
BackgroundItoh, M., Adachi, M., Yasui, H., Takekawa, M., Tanaka, H., & Imai, K. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0144 · Cited by 238
Persons, D. L., Yazlovitskaya, E. M., Cui, W., & Pelling, J. C. (1999) · PubMed · Cited by 270
Mikołajczyk, M., Awotunde, O. S., Muszyńska, G., Klessig, D. F., & Dobrowolska, G. (2000) · The Plant Cell · doi:10.1105/tpc.12.1.165 · Cited by 200
“BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.”
BackgroundSiwak, D. R., Shishodia, S., Aggarwal, B. B., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21216 · Cited by 236
Mitogen-Activated Protein Kinase Signaling
Kyosseva, S. V. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59008-6 · Cited by 230
Camp, H. S., Tafuri, S. R., & Leff, T. (1999) · Endocrinology · doi:10.1210/endo.140.1.6457 · Cited by 230
“growth factors, mitogens, and cellular stress (16, 17).”
BackgroundVukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232
“The blots were reacted with primary polyclonal rabbit IgG antibodies of anti-c-Jun, anti-Ser73 or anti-Ser63-Phospho-c-Jun (1:500 dilution) and thenwith a secondary antibody (1:3000 dilution) conjugated with horseradish peroxidase (donkey anti-rabbit IgG).”
BackgroundInfluentialMitogen-activated protein kinases
Arbabi, S., & Maier, R. V. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00010 · Cited by 229
Therapeutic approaches for ischemia/reperfusion injury in the liver
Fan, C., Zwacka, R. M., & Engelhardt, J. F. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900029 · Cited by 231
“The role of JNK is to phosphorylate c-Jun at Ser63/Ser-73 [87, 88, 89], and Thr-69/Thr-71 residues of ATF2, which increases the transcriptional activity of the two AP-1 proteins [90].”
BackgroundSprouty2 Inhibits the Ras/MAP Kinase Pathway by Inhibiting the Activation of Raf
Yusoff, P., Lao, D.-H., Ong, S. H., Wong, E. S. M., Lim, J., Lo, T. L., Leong, H. F., Fong, C. W., & Guy, G. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108368200 · Cited by 230
TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN INFLAMMATION
Kracht, M., & Saklatvala, J. (2002) · Cytokine · doi:10.1006/cyto.2002.0895 · Cited by 229
Lee, J.-M., Hanson, J. M., Chu, W. A., & Johnson, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100734200 · Cited by 228
Lee, R. J., Albanese, C., Stenger, R. J., Watanabe, G., Inghirami, G., Haines, G. K., Webster, M., Muller, W. J., Brugge, J. S., Davis, R. J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7341 · Cited by 226
Self-citationBalmanno, K., & Cook, S. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202647 · Cited by 227
“Furthermore, the transcriptional activity and biological half life of some Fos and Jun proteins is regulated by phosphorylation giving rise to dimers with di erent transactivation properties (reviewed by Karin and Hunter, 1995; Whitmarsh and Davis, 1996).”
BackgroundInfluentialChiu, C.-T., & Chuang, D.-M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.006 · Cited by 229
Interleukin-1 Regulates Proliferation and Differentiation of Oligodendrocyte Progenitor Cells
Vela, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1127 · Cited by 223
Anti-apoptotic effect of quercetin: Intervention in the JNK- and ERK-mediated apoptotic pathways
Ishikawa, Y., & Kitamura, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00265.x · Cited by 222
“The transacting potential of AP-1 depends on the induction and phosphorylation of AP-1 components by mitogen-activated protein (MAP) kinase”
BackgroundPatra, T., Meyer, K., Geerling, L., Isbell, T. S., Hoft, D. F., Brien, J., Pinto, A. K., Ray, R. B., & Ray, R. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009128 · Cited by 222
“c-Fos, a protein involved in AP-1 transcriptional regulation, is induced by a variety of cellular stresses that induce one or more of the MAPK pathways [23, 24].”
BackgroundKlotz, L., Pellieux, C., Briviba, K., Pierlot, C., Aubry, J., & Sies, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00255.x · Cited by 222
“p38 and JNK, once activated, phosphorylate, and thereby activate, transcription factors such as c-Jun and ATF-2 and ternary complex factors such as Elk-1 [13,14], resulting in the activation of c-fos and c-jun transcription to form the AP-1 proteins, Fos and Jun.”
BackgroundThe JNK Pathway Regulates the In Vivo Deletion of Immature CD4+CD8+ Thymocytes
Rincón, M., Whitmarsh, A., Yang, D. D., Weiss, L., Dérijard, B., Jayaraj, P., Davis, R. J., & Flavell, R. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1817 · Cited by 220
“The extracellular signal-regulated kinase (ERK) family has been associated with the proliferation and differentiation of a number of different cell types, while the c-Jun NH 2 -terminal kinase (JNK) and the p38 families have been associated with apoptotic death in several systems (4, 5).”
BackgroundResultInfluentialSelf-citationMitogen-activated protein kinase pathways in redox signaling
Torres, M. (2003) · Frontiers in Bioscience · doi:10.2741/999 · Cited by 219
“MAPK and Gene Expression The MAPK play an important role in the regulation of gene expression either by directly phosphorylating transcription factors or by activating other kinases with transcription factors as substrates (figure 4A) (reviewed in (4,164,165)).”
BackgroundPedram, A., Razandi, M., & Levin, E. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26722 · Cited by 215
Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.
Chen, N., Nomura, M., She, Q., Ma, W. Y., Bode, A. M., Wang, L. Q., Flavell, R. A., & Dong, Z. (2001) · PubMed · Cited by 213
Kiegerl, S., Cardinale, F., Siligan, C., Gross, A., Baudouin, E., Liwosz, A., Eklöf, S., Till, S., Bögre, L., Hirt, H., et al. (2000) · The Plant Cell · doi:10.1105/tpc.12.11.2247 · Cited by 204
“Nuclear targets of MAPKs can be various transcription factors, such as Ste12, c-Jun, Elk-1, and c-Myc (Karin and Hunter, 1995), but targets may also be other protein kinases, such as MAPK-activated protein kinase-2 (Stokoe et al., 1992), proteins including the epidermal growth factor receptor and the Ras exchange fact…”
BackgroundRoose, J. P., Mollenauer, M., Gupta, V. A., Stone, J., & Weiss, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4426-4441.2005 · Cited by 212
“Active Ras mediates its diverse actions by binding to different effector molecules, such as phosphoinositide 3 kinase (PI3 kinase), Ral guanine nucleotide dissociation stimulator, Ras interference gene 1, mitogen-activated protein (MAP) kinase kinase kinase 1, and Raf, leading to the activation of divergent signaling…”
BackgroundMolecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets
Kundu, J. K., & Surh, Y.-J. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.019 · Cited by 212
Advances in Carcinogenic Metal Toxicity and Potential Molecular Markers
Koedrith, P., & Seo, Y. R. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129576 · Cited by 207
Ferrer, I., Blanco, R., Carmona, M., & Puig, B. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100016 · Cited by 207
“The phosphorylation is mediated by the MAP kinase kinases (MKKs) (Raingeaud et al., 1995; Dérijard et al., 1995; Lin et al., 1995; Raingeaud et al., 1996; Whitmarsh and Davis, 1996; Enslen et al., 1998).”
Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells
Denning, G. M., Wollenweber, L. A., Railsback, M. A., Cox, C. D., Stoll, L. L., & Britigan, B. E. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5777-5784.1998 · Cited by 206
“Studies indicate that TNF-a activates at least two transcription factors that regulate IL-8 expression, namely NF-kB and AP-1, by activating MAPK signal transduction pathways (22, 25).”
BackgroundAcid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus
Souza, R. F., Shewmake, K., Terada, L. S., & Spechler, S. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.30993 · Cited by 205
Phosphorylation of c-Fos by Members of the p38 MAPK Family
Tanos, T., Marinissen, M. J., Leskow, F. C., Hochbaum, D., Martinetto, H., Gutkind, J. S., & Coso, O. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500620200 · Cited by 205
Han, Z. S., Enslen, H., Hu, X., Meng, X., Wu, I.-H., Barrett, T., Davis, R. J., & Ip, Y. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3527 · Cited by 201
“Proinflammatory cytokines, osmotic shock, and bacterial LPS can induce p38 MAPK activity, which leads to increased cytokine production (43, 74).”
BackgroundSelf-citationMatsuda, N., Morita, N., Matsuda, K., & Watanabe, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9151 · Cited by 202
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)91005-6 · Cited by 204
Cho, A., Graves, J., & Reidy, M. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2527 · Cited by 200
Lithium neuroprotection: molecular mechanisms and clinical implications
Rowe, M. K., & Chuang, D.-M. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404008385 · Cited by 197
Signal transduction and transcription factors in rheumatic disease
Firestein, G. S., & Manning, A. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<609::aid-anr3>3.0.co;2-i · Cited by 198
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3671 · Cited by 193
“Activated ERK can directly phosphorylate transcription factors, such as Elk-1, which binds to the serum-responsive element of the c-fos promoter (45, 46).”
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Gayathri, B., Manjula, N., Vinaykumar, K. S., Lakshmi, B. S., & Balakrishnan, A. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.12.003 · Cited by 191
Transforming growth factor-β signal transduction in epithelial cells
Yue, J., & Mulder, K. M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00143-7 · Cited by 193
Ras proteins in the control of the cell cycle and cell differentiation
Crespo, P., & León, J. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000645 · Cited by 189
Wang, W., Zhou, G., Hu, M. C.-T., Yao, Z., & Tan, T.-H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22771 · Cited by 191
Dunn, C., Wiltshire, C., MacLaren, A., & Gillespie, D. A. F. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00275-3 · Cited by 189
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805677105 · Cited by 186
Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer
Okoh, V., Deoraj, A., & Roy, D. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.005 · Cited by 185
“JNK also binds and phosphorylates the Elk-1 and ATF-2 transcription factors [179,180].”
GnRH Activates ERK1/2 Leading to the Induction of c-fos and LHβ Protein Expression in LβT2 Cells
Liu, F., Austin, D. A., Mellon, P. L., Olefsky, J. M., & Webster, N. J. G. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0791 · Cited by 185
Faris, M., Latinis, K. M., Kempiak, S. J., Koretzky, G. A., & Nel, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5414 · Cited by 190
“Based on the role of the JNK cascade in regulating the expression and transcriptional activation of AP-1 proteins (57, 58), we asked whether the 2336-to-2318 response element in the FasL promoter associates with members of the AP-1 protein family.”
BackgroundMethodInfluentialThe Hallmarks of Flavonoids in Cancer
Ponte, L. G. S., Pavan, I. C. B., Mancini, M. C. S., da Silva, L. G. S., Morelli, A. P., Severino, M. B., Bezerra, R. M. N., & Simabuco, F. M. (2021) · Molecules · doi:10.3390/molecules26072029 · Cited by 180
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
Self-citationFantz, D. A., Jacobs, D., Glossip, D., & Kornfeld, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102512200 · Cited by 184
Kujime, K., Hashimoto, S., Gon, Y., Shimizu, K., & Horie, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3222 · Cited by 182
“We have not investigated and identified downstream targets of p38 MAP kinase and JNK leading to RANTES gene expression (47, 49).”
BackgroundChung, J. H., Kang, S., Varani, J., Lin, J., Fisher, G. J., & Voorhees, J. J. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00009.x · Cited by 180
Cook, S. J., Aziz, N., & McMahon, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.330 · Cited by 183
“Activated MAPKs accumulate in the nucleus (13, 62, 91), where they can phosphorylate and activate the transcription factors Elk-1 and Sap1a, leading to the enhanced expression of genes such as that for c-Fos (34, 42, 43, 64, 94, 101).”
BackgroundInfluentialSUMO-1 Protease-1 Regulates Gene Transcription through PML
Best, J. L., Ganiatsas, S., Agarwal, S., Changou, A., Salomoni, P., Shirihai, O., Meluh, P. B., Pandolfi, P. P., & Zon, L. I. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00699-8 · Cited by 181
Yao, Z., Zhou, G., Wang, X. S., Brown, A., Diener, K., Gan, H., & Tan, T.-H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2118 · Cited by 180
Lee, C. A., Silva, M., Siber, A. M., Kelly, A. J., Galyov, E., & McCormick, B. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12283 · Cited by 180
Bancroft, C. C., Chen, Z., Dong, G., Sunwoo, J. B., Yeh, N. T., Park, C., & Waes, C. V. (2001) · PubMed · Cited by 199
Selective Activation of p38α and p38γ by Hypoxia
Conrad, P. W., Rust, R. T., Han, J., Millhorn, D. E., & Beitner-Johnson, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23570 · Cited by 178
Abdelli, S., Ansite, J., Roduit, R., Borsello, T., Matsumoto, I., Sawada, T., Allaman-Pillet, N., Henry, H., Beckmann, J. S., Hering, B. J., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2815 · Cited by 177
“” Both JNK and p38 activate downstream nuclear transcription factors that participate to the cellular response (40,41).”
BackgroundXu, C., Shen, G., Yuan, X., Kim, J.-H., Gopalkrishnan, A., Keum, Y.-S., Nair, S., & Kong, A.-N. T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi251 · Cited by 175
“JNK[22,25].”
BackgroundInfluentialHong Byun, E., Fujimura, Y., Yamada, K., & Tachibana, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903742 · Cited by 175
“These pathways convert a large variety of extracellular signals, leading to a wide range of cellular responses, such as growth, differentiation, inflammation, and apoptosis (32, 33).”
BackgroundCoronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 177
“MyD88-mediated pathway activates the transcription factors NF- B, AP-1 and ATF-2/jun, through the activation of mitogen-activated protein kinases (MAPKs) (Herlaar and Brown, 1999; Whitmarsh and Davis, 1996).”
Naturally occurring regulatory T cells: markers, mechanisms, and manipulation
Schmetterer, K. G., Neunkirchner, A., & Pickl, W. F. (2012) · The FASEB Journal · doi:10.1096/fj.11-193672 · Cited by 173
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Bonavia, R., Inda, M. M., Vandenberg, S., Cheng, S.-Y., Nagane, M., Hadwiger, P., Tan, P., Sah, D. W. Y., Cavenee, W. K., & Furnari, F. B. (2012) · Oncogene · doi:10.1038/onc.2011.563 · Cited by 170
Systemic Inflammatory Response Syndrome (SIRS): Molecular Pathophysiology and Gene Therapy
Matsuda, N., & Hattori, Y. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj06010x · Cited by 178
The MKK7 Gene Encodes a Group of c-Jun NH 2 -Terminal Kinase Kinases
Tournier, C., Whitmarsh, A. J., Cavanagh, J., Barrett, T., & Davis, R. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1569 · Cited by 174
“Mitogen-activated protein kinases (MAPKs) are components of pathways that relay signals to particular cell compartments in response to a diverse array of extracellular stimuli (38, 42, 63, 83).”
BackgroundSelf-citationRoose, J. P., Mollenauer, M., Ho, M., Kurosaki, T., & Weiss, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01882-06 · Cited by 172
“Activation of Ras was analyzed by a RasGTP pull-down assay (15 l of RAF-1 RBD agarose and 10 106 cells) according to the manufacturer’s instructions (Upstate) as described before (32).”
BackgroundInfluentialProlyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer
Ryo, A., Liou, Y.-C., Lu, K. P., & Wulf, G. (2003) · Journal of Cell Science · doi:10.1242/jcs.00276 · Cited by 173
“…which phosphorylate Jun on two critical Nterminal Ser-Pro motifs at Ser63 and Ser73, thereby enhancing its transcriptional activity (Albanese et al., 1999; Albanese et al., 1995; Bakiri et al., 2000; Binetruy et al., 1991; Derijard et al., 1994; Shaulian and Karin, 2001; Whitmarsh and Davis, 1996).”
BackgroundThe angiotensin II type 2 receptor: an enigma with multiple variations
Gallinat, S., Busche, S., Raizada, M. K., & Sumners, C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e357 · Cited by 174
“A further rationale was that PP-2A and MKP-1, both of which are activated through AT2 receptors, are powerful inhibitors of Erk1/Erk2 (100, 160).”
BackgroundInfluentialReactive oxygen species and silica‐induced carcinogenesis
Shi, X., Castranova, V., Halliwell, B., & Vallyathan, V. (1998) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937409809524551 · Cited by 170
(2001) · PubMed · Cited by 170
Smith, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00422 · Cited by 168
Nelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., Legro, R. S., Kimball, S. R., Strauss, J. F., & McAllister, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0178 · Cited by 167
Cellular and sub-cellular responses to UVA in relation to carcinogenesis
Ridley, A. J., Whiteside, J. R., McMillan, T. J., & Allinson, S. L. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902740150 · Cited by 166
Ludwig, S., Ehrhardt, C., Neumeier, E. R., Kracht, M., Rapp, U. R., & Pleschka, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009902200 · Cited by 166
The 2 Faces of JNK Signaling in Cancer
Tournier, C. (2013) · Genes & Cancer · doi:10.1177/1947601913486349 · Cited by 165
“family.(17) Transcriptional regulation of genes via AP-1 activity is one mechanism by which the JNK signaling pathway regulates cellular functions.”
BackgroundLoss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers
Kumar, A., Khandelwal, N., Malya, R., Reid, M. B., & Boriek, A. M. (2004) · The FASEB Journal · doi:10.1096/fj.03-0453com · Cited by 167
“GST-Jun-(1-79) was visualized by staining with Coomassie brilliant blue, and the dried gel was exposed to X-ray film to see the radioactive bands of GST-cJun (1-79).”
MethodInfluentialBuck, M., Poli, V., Hunter, T., & Chojkier, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00374-4 · Cited by 162
Aiba, S., Manome, H., Nakagawa, S., Mollah, Z. U. A., Mizuashi, M., Ohtani, T., Yoshino, Y., & Tagami, H. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12065.x · Cited by 160
“Activated MAPK then phosphorylate their respective substrate on serine or threonine residues (Whitmarsh and Davis, 1996; Minden and Karin, 1997; Ip and Davis, 1998).”
BackgroundLi, L., Sawamura, T., & Renier, G. (2004) · Circulation Research · doi:10.1161/01.res.0000124920.09738.26 · Cited by 161
Troussard, A. A., Tan, C., Yoganathan, T. N., & Dedhar, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7420 · Cited by 159
“Targets of the JNK signal transduction pathway include the transcription factor c-jun (50).”
BackgroundUrsolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.
Subbaramaiah, K., Michaluart, P., Sporn, M. B., & Dannenberg, A. J. (2000) · PubMed · Cited by 176
Wu, H.-H., Hwang-Verslues, W. W., Lee, W.-H., Huang, C.-K., Wei, P.-C., Chen, C.-L., Shew, J.-Y., Lee, E. Y.-H. P., Jeng, Y.-M., Tien, Y.-W., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141702 · Cited by 157
“(M) Time-course ChIP of NF-B, AP1, ATF2, or AML1 on the chemokine promoters in CFPAC-1 cells treated with 50 ng/ml rIL17B.”
BackgroundInfluentialConstitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor
Antonyak, M. A., Moscatello, D. K., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2817 · Cited by 159
Wysk, M., Yang, D. D., Lu, H.-T., Flavell, R. A., & Davis, R. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3763 · Cited by 157
Self-citationZhu, X., Wen, Z., Xu, L. Z., & Darnell, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6618 · Cited by 158
Localized pancreatic NF-κB activation and inflammatory response in taurocholate-induced pancreatitis
Vaquero, E. C., Gukovsky, I., Zaninovic, V., Gukovskaya, A. S., & Pandol, S. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1197 · Cited by 156
“AP-1 represents a homo- or heterodimer complex composed of Jun, Fos, or activating transcription factor subunits (22, 49).”
BackgroundEGF‐R regulates MMP function in fibroblasts through MAPK and AP‐1 pathways
Kajanne, R., Miettinen, P., Mehlem, A., Leivonen, S., Birrer, M., Foschi, M., Kähäri, V., & Leppä, S. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21041 · Cited by 157
“One of the major downstream effectors for MAPKs is the signal inducible transcription factor activator protein-1 (AP-1) (Whitmarsh and Davis, 1996).”
BackgroundHood, J. D., & Granger, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23504 · Cited by 171
Froy, O. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00590.x · Cited by 152
“In mammals, three major MAPK pathways have been identified: MAPK/ERK, MAPK/JNK and MAPK/p38 (Whitmarsh and Davis, 1996; Platanias, 2003).”
BackgroundInfluentialIschemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2
Maulik, N., Yoshida, T., Zu, Y.-L., Sato, M., Banerjee, A., & Das, D. K. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.5.h1857 · Cited by 155
Shi, Z.-Q., Lu, W., & Feng, G.-S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4904 · Cited by 153
Reddy, V. A., Iwama, A., Iotzova, G., Schulz, M., Elsasser, A., Vangala, R. K., Tenen, D. G., Hiddemann, W., & Behre, G. (2002) · Blood · doi:10.1182/blood.v100.2.483 · Cited by 152
Chandler, L. J., Sutton, G., Dorairaj, N. R., & Norwood, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003390200 · Cited by 153
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy
Sakai, N., Wada, T., Furuichi, K., Iwata, Y., Yoshimoto, K., Kitagawa, K., Kokubo, S., Kobayashi, M., Hara, A., Yamahana, J., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.08.039 · Cited by 152
One-way Cross-talk between p38MAPK and p42/44MAPK
Singh, R. P., Dhawan, P., Golden, C., Kapoor, G. S., & Mehta, K. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19593 · Cited by 162
Metadata
- Authors
- Whitmarsh, A. J., & Davis, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Molecular Medicine
- Published
- 1996-10
- Volume
- 74
- Issue
- 10
- Pages
- 589-607
- ISSN
- 0946-2716 (ISSN-L)
- OpenAlex
- W2031272027
- Cited by
- 1,543
- References
- 207
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 27 · 2019: 20 · 2018: 28 · 2017: 29 · 2016: 29 · 2015: 39 · 2014: 34 · 2013: 40 · 2012: 37
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AP-1 transcription factor, mitogen-activated protein kinase, ERK, c-Jun N-terminal kinase, p38 MAPK, MAPK signaling, transcriptional regulation, dual phosphorylation, signal transduction
- MeSH terms
- Animals, Humans, Mammals, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.